BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8477607)

  • 1. Successful treatment of pyoderma gangrenosum with topical 5-aminosalicylic acid.
    Sanders CJ; Hulsmans RF
    Cutis; 1993 Apr; 51(4):262-4. PubMed ID: 8477607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of peristomal pyoderma gangrenosum with topical crushed dapsone.
    Handler MZ; Hamilton H; Aires D
    J Drugs Dermatol; 2011 Sep; 10(9):1059-61. PubMed ID: 22052278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of pyoderma gangrenosum with topical 0.5% nicotine cream.
    Patel GK; Rhodes JR; Evans B; Holt PJ
    J Dermatolog Treat; 2004 Apr; 15(2):122-5. PubMed ID: 15204166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful tacrolimus (FK506) therapy in a child with pyoderma gangrenosum.
    Deckers-Kocken JM; Pasmans SG
    Arch Dis Child; 2005 May; 90(5):531. PubMed ID: 15851442
    [No Abstract]   [Full Text] [Related]  

  • 5. Pyoderma gangrenosum associated with inflammatory bowel disease. Report of two cases with good response to infliximab.
    Carrasco Cubero C; Ruiz Tudela MM; Salaberri Maestrojuan JJ; Pérez Venegas JJ
    Reumatol Clin; 2012; 8(2):90-2. PubMed ID: 22104047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyoderma gangrenosum in a patient with collagenous colitis.
    Batra AK; Levey JM; Trister J; Patwardhan R
    J Am Acad Dermatol; 2003 Nov; 49(5 Suppl):S277-9. PubMed ID: 14576653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
    Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
    Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous cyclosporine therapy in the treatment of pyoderma gangrenosum secondary to Crohn's disease.
    Carp JM; Onuma E; Das K; Gottlieb AB
    Cutis; 1997 Sep; 60(3):135-8. PubMed ID: 9314617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of high-dose immunoglobulin in the treatment of pyoderma gangrenosum.
    Hagman JH; Carrozzo AM; Campione E; Romanelli P; Chimenti S
    J Dermatolog Treat; 2001 Mar; 12(1):19-22. PubMed ID: 12171682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical disodium cromoglycate in the management of pyoderma gangrenosum.
    Massone L; Borghi S; Pestarino A; Gambini C
    Cutis; 1988 Nov; 42(5):459-62. PubMed ID: 3143520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early diagnosis and early corticosteroid administration improves healing of peristomal pyoderma gangrenosum in inflammatory bowel disease.
    Funayama Y; Kumagai E; Takahashi K; Fukushima K; Sasaki I
    Dis Colon Rectum; 2009 Feb; 52(2):311-4. PubMed ID: 19279428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of infliximab in pyoderma gangrenosum.
    Hewitt D; Tait C
    Australas J Dermatol; 2007 May; 48(2):95-8. PubMed ID: 17535196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical tacrolimus (FK506) in the treatment of recalcitrant parastomal pyoderma gangrenosum associated with Crohn's disease: report of two cases.
    Khurrum Baig M; Marquez H; Nogueras JJ; Weiss EG; Wexner SD
    Colorectal Dis; 2004 Jul; 6(4):250-3. PubMed ID: 15206967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pustular pyoderma gangrenosum.
    Leger M; Newlove T; Chu J; Meehan S; Stein J
    Dermatol Online J; 2011 Oct; 17(10):17. PubMed ID: 22031643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A woman with painful ulcera on her lower leg].
    Schreuder RM; Horváth B; van Dullemen HM
    Ned Tijdschr Geneeskd; 2015; 159():A8783. PubMed ID: 26131750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of idiopathic pyoderma gangrenosum during treatment with anti-tumor necrosis factor alfa monoclonal antibody.
    Dini V; Romanelli M; Bertone M; Talarico S; Bombardieri S; Barachini P
    Int J Low Extrem Wounds; 2007 Jun; 6(2):108-13. PubMed ID: 17558009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyoderma gangrenosum as initial manifestation of Graves' disease.
    Livideanu C; Lipsker D; Paul C; Juillard J; Schubert B
    Clin Exp Dermatol; 2006 Sep; 31(5):659-61. PubMed ID: 16780496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful acute treatment of chronic inflammatory intestinal diseases with oral 5-aminosalicylic acid].
    Maier K; Frühmorgen P; Bode JC; Heller T; von Gaisberg U; Klotz U
    Dtsch Med Wochenschr; 1985 Mar; 110(10):363-8. PubMed ID: 2857633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined therapy for pyoderma gangrenosum.
    Rozin AP; Balbir-Gurman A; Gilead L; Slodownik D
    Ann Rheum Dis; 2004 Jul; 63(7):888-9. PubMed ID: 15194593
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of Crohn's disease with peroral 5-aminosalicylic acid.
    Rasmussen SN; Binder V; Maier K; Bondesen S; Fischer C; Klotz U; Hansen SH; Hvidberg EF
    Gastroenterology; 1983 Dec; 85(6):1350-3. PubMed ID: 6354827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.